StockMarketLoopMaking Easy MoneySubscribe
Analysis$CAPR

The Shorts in $CAPR Keep Pressing. What If That's the Mistake?

Short volume is a clue, not a confession. My read on what it does and doesn't say about Capricor Therapeutics.

The Shorts in $CAPR Keep Pressing. What If That's the Mistake?

Listen: hear this article read aloud (about 2 min).

Somebody is still shorting Capricor Therapeutics into this, and the FINRA data doesn't care about anyone's opinion. It counts.

$CAPR sits at $8.60, $2.63 below its 20-day high of $11.23 and $2.93 above its 20-day low of $5.67.

My read: lean bullish. Buyers are close enough to force the issue, but I want volume before I call it a breakout.

A short that will not fall

Against its own 60-session range, $CAPR is 23.4% below the high of $11.23 (Nov 11) and 51.7% above the low of $5.67 (Oct 27).

$CAPR closed higher in 3 of its last 9 sessions. Volume over the last five sessions averaged 1.5x the twenty sessions before them.

The largest one-day move in the past twenty sessions was +26.5% on Nov 11. 65% of CAPR's off-exchange volume printed as short sales (FINRA daily short volume), against a normal 54%.

Days to cover: 7.4. Every short in the name needs 7.4 full days of normal volume to get out.

What I make of it: a crowded short matters only if the stock stops falling, and then covering becomes buying. Whether that starts here is the whole question.

What is already in the price

Off-exchange trading: NORMAL: $241K block at $8.26, under half yesterday's biggest. Biggest single off-exchange print: 29,200 shares at $8.26, about $241K, on an uptick (buyer lifted). A print that size is one order being crossed away from the public book, not a crowd of small trades. In options, dealers short gamma, call wall $9.00, put wall $6.00, gamma flip near $2.00, 100% of open options expire today, hedge pressure 0% of an average day's volume.

Days to cover 7.4, 18.8M shares short, short interest -5.5% since the last report. Squeeze risk 31 of 100; shorts pressing 78 of 100.

Across the broader market, the read is Lean bearish (bias -37).

Sentiment readings show bearish (-56 of 100).

What I make of it: the pieces mostly point the same way as the price, which is more than I can say for most setups. None of them is proof.

The bull case

  • Short squeeze setup with a measured path to $11.23

The bear case

  • Backdrop: Lean bearish (bias -37)
  • Borrow cost decides who exits first

The detail that changes the read

What I think traders are overlooking is how close the call wall sits to my target. The strike where the calls are stacked can pull price toward it or pin it there, and that makes it a level to watch, not a prediction.

That part doesn't show up on the chart.

The call, and the line that breaks it

If $CAPR posts a close above the recent high on rising volume and volume expands, I think $11.23 becomes the next serious test. Under $7.74, I'm wrong.

The honest objection is that short volume is not a short position. A high ratio is routine in liquid names, and sometimes the shorts are simply right.

So the plan is simple. Wait for the level, wait for the volume, and respect the line.

Kill switch

Any one of these and the thesis is over, no averaging down, no renaming it.

  • A close through $7.74.
  • Selling absorbs the buying at a key level and price loses it on volume.
  • Order flow reverses: the sweeps and blocks turn to the other side.
  • A scheduled event changes the picture before the trigger is reached.

Where I land

Buyers are close enough to force the issue. I want the volume before I call it anything more than a lean.

Desk record. 50 of 330 scenario targets traded before their invalidation (15%), 204 stopped out, 76 ran out of time, average outcome -0.92% per piece. Past pieces say nothing about this one.

The desk's scenario leans bullish. Bull or bear, the kill switch above is what keeps either view honest.

Sources and further reading: SEC EDGAR filings for CAPR · FINRA daily short sale volume files · Nasdaq short interest: CAPR · Cboe options quotes: CAPR · Capricor Therapeutics Inc investor site · CAPR quote, chart and data on StockMarketLoop.

Data as of Nov 20, 7:34 AM ET: options positioning, FINRA short volume, the off-exchange trade record, the structure map, SEC filings and the ticker's headlines. Vaughn McNair (Grandmaster-Obi) and Making Easy Money may hold or trade positions in the names discussed. This is speculation and education, not financial advice.

Author disclosure: educational scenario from the Academy data desk; the author may hold or trade positions in the names discussed. This is not financial advice.
Share card
Making Easy Money

Sign up now to get access to the library of members-only issues.

Free. Confirm by email. One click to leave.

Discussion (0)

Sign in to join the discussion.